Skip to main content

Table 1 Drug resistance of Mtb strains stratified by lineages and compensatory mutations in eastern China

From: Evolution and epidemic success of Mycobacterium tuberculosis in eastern China: evidence from a prospective study

Drug resistance

Overall

Lineages

P

Compensatory mutations

P

Lineage 2

Lineage 4

0

≥1

Overall (n, %)

997 (100.00)

802 (80.44)

195 (19.56)

-

793 (79.54)

204 (20.46)

-

Sampling region

0.454

  

0.131

Zhejiang

733 (73.52)

585 (79.81)

148 (20.19)

 

592 (80.76)

141 (19.24)

 

Shanghai

264 (26.48)

217 (82.20)

47 (17.80)

 

201 (76.14)

63 (23.86)

 

Susceptibility profile (n, %)

0.375*

  

< 0.001*

Sensitive

726 (72.82)

577 (79.48)

149 (20.52)

 

603 (83.06)

123 (16.94)

 

Non-MDR

199 (19.96)

164 (82.41)

35 (17.59)

 

158 (79.40)

41 (20.60)

 

MDR

51 (5.12)

45 (88.24)

6 (11.76)

 

27 (52.94)

24 (47.06)

 

Pre-XDR

21 (2.11)

16 (76.19)

5 (23.81)

 

5 (23.81)

16 (76.19)

 

Drug resistance (n, %)

    

INH-resistant

152 (15.25)

121 (79.61)

31 (20.39)

0.864

93 (61.18)

59 (38.82)

< 0.001

RFP-resistant

89 (8.93)

77 (86.52)

12 (13.48)

0.169

45 (50.56)

44 (49.44)

< 0.001

EMB-resistant

66 (6.62)

54 (81.82)

12 (18.18)

0.896

31 (46.97)

35 (53.03)

< 0.001

PZA-resistant

46 (4.61)

39 (84.78)

7 (15.22)

0.569

18 (39.13)

28 (60.87)

< 0.001

SM-resistant

123 (12.34)

107 (86.99)

16 (13.01)

0.067

76 (61.79)

47 (38.21)

< 0.001

FLQ-resistant

61 (6.12)

47 (77.05)

14 (22.95)

0.601

39 (63.93)

22 (36.07)

0.003

AM-resistant

14 (1.40)

13 (92.86)

1 (7.14)

0.326*

7 (50.00)

7 (50.00)

0.013*

KM-resistant

8 (0.80)

6 (75.00)

2 (25.00)

0.658*

4 (50.00)

4 (50.00)

0.060*

CM-resistant

8 (0.80)

7 (87.50)

1 (12.50)

1.000*

6 (75.00)

2 (25.00)

0.670*

ETO-resistant

36 (3.61)

28 (77.78)

8 (22.22)

0.844

19 (52.78)

17 (47.22)

< 0.001

PAS-resistant

10 (1.00)

8 (80.00)

2 (20.00)

1.000*

8 (80.00)

2 (20.00)

1.000*

  1. Note: *Fisher’s exact test. INH, isoniazid; RFP, rifampicin; EMB, ethambutol; PZA, pyrazinamide; SM, streptomycin; FLQ, fluoroquinolones; AM, amikacin; KM, kanamycin; CM, capreomycin; ETO, ethionamide; PAS, para-aminosalicylic acid